Vital Pulp Therapy With Different Materials for Young Permanent Teeth

Sponsor
Mansoura University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05498337
Collaborator
(none)
100
2
18

Study Details

Study Description

Brief Summary

This study will be conducted to:
Evaluate clinically and radiographically apexogenesis in immature permanent molars using:
  1. Calcium Hydroxide.

  2. MTA.

  3. Laser.

  4. Laser combined with MTA.

Condition or Disease Intervention/Treatment Phase
  • Other: calcium hydroxide
  • Other: MTA
  • Device: Diode Laser
N/A

Detailed Description

Calcium Hydroxide has been the most commonly utilized pulpotomy agent for vital pulp therapy. It is the earliest medicament employed in pulpotomy that possesses the ability to stimulate tertiary dentinogenesis. This is attributed to its high alkalinity after mixing with water. Calcium hydroxide has a high pH, and its dental use relates chiefly to its ability to stimulate mineralization and also to its antibacterial property.

Biocompatibility and sealing ability are the most important properties, which account for optimal healing response in vital pulp therapy. Unlike conventional materials, MTA has low solubility and maintains its physical integrity after placement. It has several desirable characteristics in terms of biocompatibility, bioactivity, hydrophilicity, radiopacity, sealing ability and low solubility.

Diode laser in a young permanent tooth with traumatically exposed pulp has proved to be an effective technique for Pulpotomy in an immature tooth. Therefore, the use of soft-tissue diode lasers can influence the treatment outcome and should be seen as a predicable tool for vital pulp therapy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of Different Treatment Modalities for Vital Pulp of Immature Permanent Molars
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Examiner

Examiner

Other: calcium hydroxide
Dental pulp medicament material

Other: MTA
Dental pulp medicament material

Device: Diode Laser
Device used in pulp therapy

No Intervention: Patient

Patient

Outcome Measures

Primary Outcome Measures

  1. Root completion [one year]

    Closure of radiographic apex using Scanora 5.2.6 digital software

Secondary Outcome Measures

  1. Root lengthening and thickening [one year]

    Measuring the increase in length and width of the root canals using Scanora 5.2.6 digital software

Other Outcome Measures

  1. Clinical evaluation [one year]

    Absence of pain and tenderness to percussion using facial scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 9 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Medically free

  • Vital teeth

Exclusion Criteria:
  • Medically compromised

  • Chronic abscess

  • Non-vital teeth

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Study Director: Salwa M Awad, Professor, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nada mohamed, Assistant lecturer, Mansoura University
ClinicalTrials.gov Identifier:
NCT05498337
Other Study ID Numbers:
  • Vital pulp therapy
First Posted:
Aug 12, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nada mohamed, Assistant lecturer, Mansoura University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2022